Innovative Recruitment and Retention Strategies for Phase III Rare Cardiovascular Disease Study

CRO strategy supports rare patient recruitment efforts

September 29, 2020
Eteri Tsetskhladze, MD, PhD, FESC, FACC | Karen Hill

See how Worldwide’s expertise in cardio patient recruitment strategies helped address three concerns during this phase III PAH clinical study.

Your form has been successfully submitted! Click the button below to access.
VIEW PDF
Eteri Tsetskhladze, MD, PhD, FESC, FACC
MEET THE AUTHOR

Eteri Tsetskhladze, MD, PhD, FESC, FACC

Vice President, General Medicine Medical Lead, Medical Affairs
LEARN MORE
Karen Hill
MEET THE AUTHOR

Karen Hill

Senior Vice President, Project Management, Cardiovascular, Endocrine & Metabolic and Real-World Evidence
LEARN MORE